TREA

97191384 - CONJUALL

Follow

Information

  • Trademark
  • 97191384
  • Serial Number
    97191384
  • Registration Number
    7477524
  • Filing Date
    December 27, 2021
    2 years ago
  • Registration Date
    August 20, 2024
    2 months ago
  • Transaction Date
    August 20, 2024
    2 months ago
  • Status Date
    August 20, 2024
    2 months ago
  • Published for Opposition Date
    June 04, 2024
    5 months ago
  • Location Date
    August 19, 2024
    2 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    FIRST, VIVIAN M
  • Attorney Docket Number
    TWL.ITU1T
    Attorney Name
    Corey K. Cho
  • Owners
Information
Mark Drawing Code
4
Mark Identification
CONJUALL
Case File Statements
  • GS0051: Medicinal preparations for prevention and treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases, namely, antibodies, antibody conjugates and active ingredients and antibody conjugates; chemical reagents for medical use, especially chemical reagents for linking molecules for medical use; colostral antibodies and the chemical modifications and conjugates thereof for medical purposes and medical laboratory tests; drug delivery agents consisting of compounds that facilitate delivery of pharmaceuticals for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biological preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; Chemical preparations for pharmaceutical purposes for the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical pharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; medical molecular diagnostic reagents for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; biopharmaceuticals for use in relation to the treatment of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical preparations for treatment of rare diseases
  • GS0421: Scientific study and research in the field(s) of research on the subject of pharmaceuticals; development of pharmaceutical preparations and medicines; medical and pharmaceutical research services; biological research and analysis; chemical research and analysis; biochemical research and analysis; and scientific research in the nature of conducting clinical trials for others
Case File Event Statements
  • 12/30/2021 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 9/28/2022 - 2 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/4/2022 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/29/2022 - 2 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/29/2022 - 2 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/29/2022 - 2 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/17/2023 - a year ago
    11 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 2/22/2023 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/22/2023 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 2/22/2023 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/17/2023 - a year ago
    10 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 3/17/2023 - a year ago
    12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 9/14/2023 - a year ago
    14 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 9/14/2023 - a year ago
    13 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 9/14/2023 - a year ago
    15 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 9/27/2023 - a year ago
    17 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 5/2/2024 - 6 months ago
    23 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/2/2024 - 6 months ago
    20 - ASSIGNED TO LIE Type: ALIE
  • 5/2/2024 - 6 months ago
    21 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/2/2024 - 6 months ago
    22 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/15/2024 - 6 months ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/4/2024 - 5 months ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/4/2024 - 5 months ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/20/2024 - 2 months ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/20/2024 - 2 months ago
    28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 12/12/2023 - 11 months ago
    19 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 9/27/2023 - a year ago
    16 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 9/27/2023 - a year ago
    18 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA